# Integrated single-cell and spatial transcriptomics reveal the differentiation drivers of gastric epithelial lineage progression

**Authors:** Xuyu Chen, Xin Jiang, Siying Wang, Jianlei Xia, Wenjun Wang, Xinyu Fu, Ping Yukun, Zhuoqi Liu, Yaoyao Li, Min Zhang, Yanbing Ding

PMC · DOI: 10.3389/fimmu.2026.1712830 · Frontiers in Immunology · 2026-02-09

## TL;DR

This study combines single-cell and spatial transcriptomics to uncover how inflammation from H. pylori leads to gastric cancer through epithelial changes.

## Contribution

The study identifies UPP1 as a novel key regulator linking H. pylori-driven inflammation to gastric cancer progression.

## Key findings

- IM epithelium is a transitional state with enhanced WNT signaling promoting cancer progression.
- UPP1 is upregulated in malignant and H. pylori-positive epithelium and correlates with poor survival in gastric cancer.
- UPP1 knockout in organoids promotes IM-like morphology, confirming its role in epithelial reprogramming.

## Abstract

Gastric cancer (GC) develops through a sequence from chronic gastritis to intestinal metaplasia (IM) and carcinoma, with Helicobacter pylori (HP) as a key driver; however, the molecular mediators linking inflammation to malignant transformation remain unclear. We integrated single-cell RNA sequencing and spatial transcriptomics of gastric mucosal samples from atrophic gastritis, IM, and GC, including HP positive (+) and HP negative (-) cases, to map cellular heterogeneity, differentiation trajectories, and pathway activities. Our analyses revealed that IM epithelium represents a transitional state between normal and malignant epithelial lineages, characterized by enhanced WNT signaling that promotes neoplastic progression, whereas H. pylori–associated inflammation activates NF-κB signaling. Across analysis, UPP1 was consistently upregulated in malignant and H. pylori–positive epithelium, increasing along pseudotime toward cancer-like states. Spatial mapping and organoid experiments confirmed that UPP1-high cells had higher intestinal differentiation scores, while UPP1 knockout promoted IM-like morphology in WNT-depleted cultures. Clinically, UPP1 was elevated in GC versus normal tissues, correlated with advanced TNM stage, predicted poor survival, and was higher in HP+ tissues. Knockdown in GC cell lines reduced clonogenicity and migration. Collectively, these findings identify UPP1 as a key regulator of epithelial reprogramming and IM, linking H. pylori–driven inflammation with WNT-mediated differentiation, and highlight its potential as a prognostic biomarker and therapeutic target in GC.

## Linked entities

- **Genes:** UPP1 (uridine phosphorylase 1) [NCBI Gene 7378], Wnt (protein Wnt-2) [NCBI Gene 100641115], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790]
- **Diseases:** gastric cancer (MONDO:0001056), chronic gastritis (MONDO:0005001), intestinal metaplasia (MONDO:0100190)

## Full-text entities

- **Genes:** PGC (progastricsin) [NCBI Gene 5225] {aka PEPC, PGII}, HGF (hepatocyte growth factor) [NCBI Gene 3082] {aka DFNB39, F-TCF, HGFB, HPTA, SF}, WNT2B (Wnt family member 2B) [NCBI Gene 7482] {aka WNT13}, FRZB (frizzled related protein) [NCBI Gene 2487] {aka FRE, FRITZ, FRP-3, FRZB-1, FRZB-PEN, FRZB1}, EGF (epidermal growth factor) [NCBI Gene 1950] {aka HOMG4, URG}, WNT5B (Wnt family member 5B) [NCBI Gene 81029], TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, OLFM4 (olfactomedin 4) [NCBI Gene 10562] {aka GC1, GW112, OLM4, OlfD, UNQ362, bA209J19.1}, LIPF (lipase F, gastric type) [NCBI Gene 8513] {aka GL, HGL, HLAL}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, MUC5AC (mucin 5AC, oligomeric mucus/gel-forming) [NCBI Gene 4586] {aka MUC5, TBM, leB, mucin}, MS4A1 (membrane spanning 4-domains A1) [NCBI Gene 931] {aka B1, Bp35, CD20, CVID5, FMC7, LEU-16}, WNT4 (Wnt family member 4) [NCBI Gene 54361] {aka SERKAL, WNT-4}, MUC6 (mucin 6, oligomeric mucus/gel-forming (gene/pseudogene)) [NCBI Gene 4588] {aka MUC-6}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, RSPO1 (R-spondin 1) [NCBI Gene 284654] {aka CRISTIN3, RSPO}, CD79A (CD79a molecule) [NCBI Gene 973] {aka IGA, IGAlpha, MB-1, MB1}, UPP1 (uridine phosphorylase 1) [NCBI Gene 7378] {aka UDRPASE, UP, UPASE, UPP}, WNT3A (Wnt family member 3A) [NCBI Gene 89780], CDX2 (caudal type homeobox 2) [NCBI Gene 1045] {aka CDX-3, CDX2/AS, CDX3}, LGR4 (leucine rich repeat containing G protein-coupled receptor 4) [NCBI Gene 55366] {aka BNMD17, DPSL, GPR48}, CEACAM6 (CEA cell adhesion molecule 6) [NCBI Gene 4680] {aka CD66c, CEAL, NCA, NCA-50/90}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, CEACAM5 (CEA cell adhesion molecule 5) [NCBI Gene 1048] {aka CD66e, CEA}, MUC2 (mucin 2, oligomeric mucus/gel-forming) [NCBI Gene 4583] {aka MLP, MUC-2, SMUC}, NOG (noggin) [NCBI Gene 9241] {aka SYM1, SYNS1, SYNS1A}, FGF10 (fibroblast growth factor 10) [NCBI Gene 2255] {aka LADD3}
- **Diseases:** metaplasia (MESH:D008679), chronic (MESH:D002908), chronic gastritis (MESH:D005756), IM (MESH:D007410), carcinogenesis (MESH:D063646), Gastric (MESH:D013272), GC (MESH:D013274), pancreatic intraepithelial neoplasia (MESH:D002578), infected (MESH:D007239), Tumor (MESH:D009369), carcinogenic (MESH:D011230), HP (MESH:D016481), tumorigenic (MESH:D002471), colorectal cancer (MESH:D015179), dysplasia (MESH:D015792), Chronic inflammation (MESH:D007249), AG (MESH:D005757), epithelial (MESH:D009375)
- **Chemicals:** DAPI (MESH:C007293), GlutaMax (MESH:C054122), PBS (MESH:D007854), nutlin-3 (MESH:C482205), N-acetylcysteine (MESH:D000111), SDS (MESH:D012967), paraformaldehyde (MESH:C003043), TRIzol (MESH:C411644), Nicotinamide (MESH:D009536), CO2 (MESH:D002245), luminal (MESH:D010634), A83-01 (MESH:C507011), fatty acid (MESH:D005227), streptomycin (MESH:D013307), Dexamethasone (MESH:D003907), N2 (MESH:D009584), F12 (MESH:C007782), Forskolin (MESH:D005576), P (MESH:D010758), blasticidin (MESH:C004500), HEPES (MESH:D006531), penicillin (MESH:D010406), uridine (MESH:D014529), puromycin (MESH:D011691), B27 (-), Y-27632 (MESH:C108830), crystal violet (MESH:D005840), S (MESH:D013455)
- **Species:** Mycoplasma (genus) [taxon 2093], Homo sapiens (human, species) [taxon 9606], Helicobacter pylori (species) [taxon 210], Mus musculus (house mouse, species) [taxon 10090], Hepacivirus P (species) [taxon 2202225]
- **Cell lines:** AGS — Homo sapiens (Human), Gastric adenocarcinoma, Cancer cell line (CVCL_0139), HGC27 — Homo sapiens (Human), Gastric carcinoma, Cancer cell line (CVCL_1279), GES-1 — Homo sapiens (Human), Transformed cell line (CVCL_EQ22), MKN74 — Homo sapiens (Human), Gastric tubular adenocarcinoma, Cancer cell line (CVCL_2791), PMC — Mus musculus (Mouse), Transformed cell line (CVCL_U367), MKN45 — Homo sapiens (Human), Gastric adenocarcinoma, Cancer cell line (CVCL_0434), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), MKN1 — Homo sapiens (Human), Gastric adenosquamous carcinoma, Cancer cell line (CVCL_1415)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12926446/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12926446/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC12926446/full.md

---
Source: https://tomesphere.com/paper/PMC12926446